Understanding Gut Health:
A Guide to Digestion, the Microbiome and Common Symptoms

Call 999 or go to A&E for an emergency

A sudden, severe stomach ache, pain when the abdomen is touched, vomiting blood or vomit that looks like coffee grounds, substantial rectal bleeding, or black, sticky, tar-like stools with abdominal pain needs emergency assessment. Being unable to pass stool or wind with abdominal pain can indicate a blockage. Do not wait for a routine appointment. Severe difficulty breathing, collapse, confusion or abnormal responsiveness also needs immediate help.

Green vomit in an adult can be a sign of a serious problem and needs emergency assessment. If you are uncertain how to travel safely, call 999. Tell the call handler when symptoms started, whether the person is conscious and breathing, and about any relevant diagnosis, operation or medicine.

A severe allergic reaction can progress quickly. If anaphylaxis is suspected, use prescribed emergency adrenaline immediately and call 999, saying “anaphylaxis”, even if the person starts to improve. Follow the emergency instructions supplied with the prescribed device and tell the call handler if a second dose is needed.

Get urgent advice before symptoms become dangerous

Contact a GP urgently or use NHS 111 for abdominal pain that suddenly worsens, abdominal pain during pregnancy, blood in the stool or bloody diarrhoea, or vomiting that continues or prevents you keeping fluids down. Dehydration that persists despite attempts at oral rehydration also needs advice. If you are severely unwell, do not wait for a routine call-back.

NHS guidance advises seeking help for diarrhoea lasting more than seven days or vomiting lasting more than two days. Earlier advice may be appropriate if a person is vulnerable, has serious underlying illness, is deteriorating or cannot drink. Passing very little urine, dizziness or unusual drowsiness adds concern.

Arrange assessment of persistent unexplained bowel change, weight loss, anaemia, swallowing difficulty, recurrent bleeding, a new mass, persistent vomiting or progressive symptoms. These can have many causes, but a familiar label such as IBS does not explain away a new warning sign.

How to use this book

The digestive system can produce similar symptoms for very different reasons. This book explains mechanisms, possible explanations, investigation and care; it cannot diagnose you from a symptom pattern. You do not have to wait until a symptom is extreme before asking for help.

Sources appear with each section so you can follow the clinical guidance and research yourself. Targeted research was gathered on 2 November 2026; it was not a systematic review. Guidelines change, and decisions depend on the person, local services and current recommendations. This manuscript has not received an independent clinical review or complete claim-by-claim source audit.

From mouth to stomach

Digestion begins before food reaches the stomach. Chewing breaks food into smaller pieces and mixes it with saliva. Salivary enzymes begin the breakdown of starch; swallowing then moves the food bolus through the pharynx into the oesophagus, a muscular tube connecting the throat and stomach.

Coordinated waves of muscle contraction move food along the oesophagus. A muscular valve at its lower end helps limit the return of stomach contents. The stomach stores and mixes food with acid and enzymes, beginning protein digestion and gradually releasing a liquid mixture called chyme into the small intestine.

The stomach is an active mixing chamber. Its emptying rate and the amount released into the small bowel are regulated. Problems at different points can produce overlapping symptoms such as nausea, fullness, pain or regurgitation.

Small intestine, large intestine and exit

The small intestine has three regions: duodenum, jejunum and ileum. Here, food mixes with pancreatic secretions, bile and intestinal enzymes. Most digestion and nutrient absorption take place across its extensive folded surface. Nutrients then travel through blood or lymph to tissues.

The large intestine includes the colon and rectum. It absorbs water and electrolytes from material passing through it, while the remaining contents become stool. The rectum stores stool until coordinated nerves, muscles and conscious relaxation permit defecation.

A change at one point can affect what happens downstream. For example, material arriving in the colon carries water and nutrients that were not absorbed earlier. Bowel symptoms alone cannot identify which part of the system is responsible.

The liver, gallbladder and pancreas

The liver makes bile, which helps the intestine handle dietary fat. The gallbladder stores bile and releases it into the small intestine through ducts. The pancreas contributes digestive enzymes and bicarbonate to the small intestine; it also has a separate hormone-producing role in glucose regulation.

A blockage in a bile duct, inflammation of the pancreas or a disorder of the stomach can cause upper abdominal symptoms, but pain location alone is not enough to tell them apart. The history, examination and suitable tests help distinguish them.

The liver, pancreas and bowel work together, but the same complaint does not imply that all three need testing. Investigations should have a clinical reason and a plan for what an abnormal result would mean.

Carbohydrates, proteins and fats

Enzymes break complex carbohydrates into smaller sugars, proteins into amino acids and smaller peptides, and fats into components that can be absorbed. These reactions happen in stages: stomach acid and enzymes help with proteins, while pancreatic and intestinal enzymes continue digestion in the small bowel.

Bile helps fat disperse into smaller droplets so enzymes can act on it. The products of fat digestion are absorbed through the intestinal lining and carried partly through the lymphatic system. Most sugars and amino acids enter the bloodstream after absorption.

Unabsorbed material continues into the colon, where microbes can ferment some carbohydrates. Gas after eating is a biological process, but troublesome or changing symptoms deserve their own assessment.

Water, electrolytes and the final stool

Digestive secretions add fluid to the contents of the gut. Much of that fluid, together with water consumed in food and drink, is absorbed again as it moves through the small and large intestines. The colon recovers water and salts from the remaining material.

Diarrhoea can develop when more fluid enters the bowel, less is absorbed, or transit and other mechanisms alter the balance. Different conditions can produce a watery stool by different routes. The consistency is useful information but does not identify the cause by itself.

During prolonged or heavy diarrhoea, loss of fluid and electrolytes can be clinically important. An oral rehydration solution may help replace both; persistent inability to drink or signs of dehydration require timely advice.

What malabsorption may look like

Malabsorption means that nutrients are not absorbed adequately. Clues can include weight loss, deficiencies or stools that are bulky, pale, greasy, difficult to flush or unusually foul-smelling. These observations are not specific: a person may have malabsorption without all of them, and similar stools can have other explanations.

Possible causes include disease affecting the small intestinal lining, problems delivering or using digestive enzymes, and conditions affecting bile. Coeliac disease is one example of small-bowel disease. A clinician chooses tests from the history and examination instead of treating a stool description as a diagnosis.

Unexplained weight loss, nutritional deficiencies or persistent changes deserve assessment. Replacing a deficiency may be necessary, but the reason for it also needs attention.

The gut has coordinated movement

Muscles in the digestive tract contract in coordinated patterns. Peristalsis propels contents onwards; other contractions mix them with digestive secretions and bring them into contact with the lining. These patterns vary by region and by whether the gut is processing a meal.

The stomach releases its contents gradually into the small intestine. The small intestine mixes and advances them; the colon moves remaining material towards the rectum. The time taken is not the same in every person or after every meal.

A disorder of movement may be considered when the pattern fits, but nausea, constipation or bloating does not prove a particular motility problem. Gastroparesis is delayed stomach emptying and is assessed in the appropriate clinical setting, not assumed from fullness after food.

Passing stool involves more than the colon

As stool enters and stretches the rectum, nerves help generate the urge to open the bowels. The pelvic floor and anal sphincter muscles must coordinate with abdominal pressure and relaxation. Stool consistency, movement through the bowel and the circumstances in which someone can use a toilet all contribute.

Constipation can mean hard stools, difficulty or discomfort passing them, a sense of incomplete emptying, or opening the bowels less often than usual. Frequency alone can miss a problem: someone who goes daily may still strain or feel unable to empty.

Loose stool can sometimes leak around impacted hard stool. This is one reason why persistent apparent diarrhoea and constipation both benefit from a careful history and, when appropriate, examination rather than a quick assumption about transit speed.

Pain and distension are signals with several possible sources

The gut wall contains sensory nerves that respond to stretch and other signals. Some people experience stronger discomfort from intestinal sensations, sometimes called visceral hypersensitivity. This is one recognised mechanism in disorders of gut-brain interaction, including IBS and functional dyspepsia.

Pain intensity cannot reliably reveal the amount of visible tissue injury. Severe pain deserves care even when investigations are normal, and a new or progressive pattern needs reassessment. Equally, sensory changes do not rule out inflammation, obstruction or another structural disease.

Distinguish the sensation of bloating from visible abdominal distension. Note when each occurs, whether it varies through the day and whether it comes with altered stool, vomiting, weight loss or pelvic symptoms. That context guides the next step.

A selective interface

The intestinal lining separates the contents of the bowel from underlying tissue while allowing controlled absorption. Its cells form a layer joined by structures including tight junctions. Mucus, secretions and immune defences also contribute to how the body manages contact with food, microbes and their products.

The barrier is selective and dynamic. Permeability can change in research and in some disease states, but a measured change is not a single diagnosis and does not establish the cause of every symptom. The specific condition, test and clinical context matter.

If inflammation damages the lining, function can change. Coeliac disease and inflammatory bowel disease illustrate different immune processes, each requiring its own assessment. A general description of a “leaky gut” cannot replace those diagnostic pathways.

Immune defence and tolerance

The gut immune system must respond to harmful organisms while maintaining appropriate tolerance to food and the many microbes that normally live in the intestine. Cells and signalling molecules in and below the lining contribute to these responses.

Coeliac disease is an immune-mediated response to gluten in susceptible people; Crohn’s disease is a different inflammatory condition. A symptom, or a nonspecific marker of inflammation, does not identify either one without further assessment.

The microbiome is discussed in the companion chapters. For the clinical questions here, its role is part of a larger system involving the lining, immune responses and motility; a microbiome description on its own does not establish a diagnosis.

Communication runs in both directions

The brain and gut communicate through neural, hormonal and immune pathways. The enteric nervous system helps coordinate gut activity, while signals between the gut and central nervous system influence sensation and function. Research also examines microbial products as part of this network.

Stress and sleep can influence digestive symptoms, and persistent pain or unpredictable bowel habits can affect sleep, mood and daily life in return. Recognising this two-way relationship does not make symptoms imaginary and does not mean every gastrointestinal complaint is caused by stress.

Mechanistic studies help researchers ask questions; they do not by themselves prove a treatment works. Treatments for IBS and functional dyspepsia are evaluated separately, including their benefits, limitations and adverse effects.

Pain, bloating and changes in stool

Pain related to defecation and a change in stool frequency or form is a common IBS pattern. But symptoms can overlap with coeliac disease, inflammatory bowel disease, infection and other conditions. A pattern helps direct questions and tests; it is not a diagnosis on its own.

Watery diarrhoea can follow infection or a medicine change and can occur with bile acid diarrhoea, microscopic colitis, coeliac disease or IBS, among other causes. Persistent greasy stool and weight loss can prompt assessment for malabsorption, including pancreatic or small-bowel problems.

Record whether symptoms wake you at night, whether you see blood, and whether there is fever, weight loss or a steadily worsening course. These details can change the urgency or direction of assessment. A normal-looking stool does not rule out disease, and stool appearance by itself cannot identify its cause.

Upper abdominal symptoms and swallowing

Heartburn is a burning feeling often associated with reflux of stomach contents. Regurgitation is the return of contents into the throat or mouth. Upper abdominal pain, burning or early fullness can also be described as dyspepsia. These labels describe experiences and do not identify every cause.

An ulcer, infection with Helicobacter pylori, medicine effects and functional dyspepsia are among the possible explanations for upper abdominal symptoms. Repeated vomiting or difficulty swallowing should not simply be labelled indigestion. Swallowing difficulty calls for assessment and can meet criteria for urgent investigation.

If symptoms accompany sudden severe pain, vomiting blood or a person becoming very unwell, use the emergency guidance at the beginning of the book. The location of pain alone cannot safely rule a serious condition in or out.

Bleeding, pelvic symptoms and what else matters

Blood may be bright red, darker, mixed with stool or not visible. Colour and quantity are helpful to report, but neither can reliably identify the source without assessment. Piles and other benign causes exist alongside more serious possibilities; a previous diagnosis of piles does not explain every new episode.

Persistent bloating, feeling full quickly, pelvic or abdominal discomfort, and urinary urgency or frequency can also have a pelvic or ovarian explanation. Tell the clinician about these symptoms even when they feel digestive. NICE uses age and symptom patterns to guide investigation.

A single symptom can arise from more than one process, and more than one condition can coexist. It is reasonable to ask what is most likely, what is being checked for, and what change would lead to a different plan.

Make a timeline

Note when symptoms started, whether onset was sudden or gradual, and whether they are constant, episodic or progressing. Describe where pain is felt, its character, severity, duration and relationship to meals or opening the bowels. Include vomiting, reflux, bloating, early fullness and any impact on work, sleep or leaving home.

For bowel changes, describe your usual pattern and what has changed: frequency, form, urgency, straining, incomplete emptying, nocturnal symptoms, visible blood or mucus. If a record helps, note approximate dates rather than trying to remember every meal or creating a restrictive routine.

A clinician also needs to know about unintended weight loss, fever, fatigue, anaemia or a new mass. These details can change the investigation pathway. A symptom being embarrassing or intermittent does not make it unimportant.

Exposures, history and medicines

Mention recent travel, sick contacts, food or water exposures, antibiotics and healthcare admissions when discussing diarrhoea. Include prior abdominal surgery, known digestive disease and family history of bowel cancer, coeliac disease or inflammatory bowel disease. A family history guides risk assessment but does not establish a diagnosis.

Bring a list of prescribed medicines, over-the-counter products, supplements and doses, including when each was started or changed. Tell the clinician about weight-loss or diabetes injections. A timing relationship may suggest a contribution, but do not stop an essential prescribed medicine without discussing a safe plan.

Explain current eating patterns and whether you still eat gluten. If coeliac testing is being considered, the testing conditions matter. Avoid eliminating several food groups before the consultation if you can do so safely; if you have already restricted them, explain what changed and why.

A shared plan for assessment

The clinician may examine the abdomen and, depending on the situation, assess weight, hydration or carry out a rectal examination. Tests are chosen to answer questions raised by the history and examination. They may be staged rather than ordered all at once.

Ask which diagnosis is being considered, what a test can and cannot tell you, and when you should expect results. If travel, disability, embarrassment or a previous difficult experience makes an examination hard, discuss support and alternatives. You can ask for an explanation and a chaperone.

Agree what to do if symptoms worsen, results are inconclusive or you do not hear back. A review date gives the assessment a next step, especially when the first results are reassuring but the problem continues.

Blood tests and coeliac serology

A full blood count can identify anaemia and other blood-cell changes. Inflammatory markers such as CRP or ESR can add context. These tests do not identify every digestive condition, and an abnormal result can have more than one cause. Other blood tests may be selected for hydration, liver function or nutritional deficiencies.

For suspected coeliac disease, NICE recommends total IgA and IgA tissue transglutaminase, often called IgA-tTG, as the first laboratory tests in adults. The laboratory uses IgG-based tests when IgA is deficient. Gluten must be present in the diet for the diagnostic process to be reliable.

A normal result can reduce the likelihood of a particular condition without ending assessment. A negative coeliac result with strong ongoing suspicion still warrants discussion and possible specialist assessment. Ask what the result means for the specific question it was meant to answer.

Calprotectin, FIT and infection testing

Faecal calprotectin measures a protein associated with intestinal inflammation. NICE supports its use in appropriate people when clinicians are deciding whether specialist investigation for inflammatory disease is needed. A raised value has several possible causes and does not by itself diagnose inflammatory bowel disease.

FIT measures tiny amounts of human haemoglobin in stool. A positive result does not mean cancer is confirmed, and a low result does not make every bowel symptom safe to ignore. Calprotectin is not a substitute for FIT or for a cancer assessment when the clinical picture calls for one.

A stool sample can also test for infection when the history suggests it. Different tests answer different questions. Recent antibiotics or healthcare exposure with diarrhoea may make C. difficile relevant; the clinician selects the appropriate test and next steps.

Endoscopy, imaging and targeted tests

Endoscopy uses a camera to inspect the digestive tract. Gastroscopy examines the upper tract; colonoscopy examines the large bowel and may allow tissue samples to be taken. Biopsies can reveal microscopic colitis even when the bowel looks normal to the naked eye.

Imaging may be chosen for suspected obstruction, gallstones or other structural problems. For persistent diarrhoea, tests for bile acid diarrhoea or pancreatic exocrine insufficiency may be considered when the history supports them. Faecal elastase can help assess pancreatic enzyme production, but a very watery stool can dilute the sample and affect interpretation.

A gastric emptying test is used when delayed emptying is suspected after appropriate assessment. No single scan or comprehensive stool panel answers every digestive question. Before a test, ask about preparation, risks, how results will be communicated and what happens next.

What IBS describes

IBS is a disorder of gut-brain interaction. Its symptoms commonly include abdominal pain or discomfort associated with defecation or changes in stool frequency or form, along with bloating or altered bowel habit. People may have diarrhoea-predominant, constipation-predominant or mixed patterns, and patterns can change over time.

IBS is a real condition. The BSG guideline describes interacting processes that can include altered gut movement, sensitivity and gut-brain signalling. There is no need to assume one mechanism applies to every person or that a distressing symptom is “only psychological”.

A clinician can make a positive diagnosis using the history, examination and limited appropriate investigations. They should consider warning features and alternative diagnoses rather than simply waiting until every possible test has been performed.

Initial assessment and practical care

NICE recommends considering IBS in adults with abdominal pain or discomfort, bloating, or a change in bowel habit for at least six months, and assessing the characteristic pattern. For people who meet its diagnostic criteria, recommended tests include a full blood count, inflammatory markers and coeliac serology. Tests are interpreted with the history and examination.

Regular meals, adequate fluid, activity suited to the person and time to eat can be discussed. If fibre is adjusted, NICE favours soluble fibre such as ispaghula over insoluble bran for IBS. A dietary change should be judged by symptom response and nutritional adequacy rather than maintained automatically.

An individual may need dietetic support for more complex dietary management. Ongoing bleeding, weight loss, persistent progressive symptoms or a new pattern deserves reassessment even if IBS has been diagnosed previously.

Treating the symptoms that matter

Treatment is selected around the person’s dominant symptoms. Depending on the situation, clinicians may consider an antispasmodic for pain, a laxative for constipation or an antidiarrhoeal medicine for diarrhoea. Benefits, contraindications and side effects should be reviewed rather than assuming every option suits everyone.

Low-dose medicines used to modulate pain signalling can be offered for some people. In the ATLANTIS primary-care trial of 463 adults, amitriptyline improved IBS severity by about 27 points more than placebo at six months, below the trial’s prespecified 35-point between-group target; global relief favoured amitriptyline. Withdrawals because of adverse events were 12.9% versus 8.7%. These results support a conversation about both possible benefit and tolerability.

Gut-directed psychological therapies are another evidence-based option for some people with persistent symptoms. They aim to alter how symptoms are managed and processed; offering them does not imply that pain is fabricated or that medical assessment should stop when new warning signs appear.

When stomach contents travel upwards

The lower oesophageal sphincter helps prevent stomach contents returning to the oesophagus. Reflux occurs when this protection is overcome and contents travel upwards. Heartburn and regurgitation are common symptoms; the severity of the sensation does not by itself show how much inflammation is present.

Occasional reflux can occur without a chronic condition. Gastro-oesophageal reflux disease, or GORD, is the clinical context in which reflux causes troublesome symptoms or complications. A clinician considers the pattern, relevant medicines and warning signs before choosing treatment or investigation.

Chest pain can have causes outside the digestive tract, including a heart emergency. Sudden severe or persistent chest pain, especially with breathlessness, sweating or pain spreading to the arm, jaw or back, requires emergency assessment rather than a reflux self-diagnosis.

Treatment and reassessment

NICE recommends an initial proton pump inhibitor, or PPI, course for people with GORD, with dose and duration depending on the presentation. It recommends a full-dose PPI for four or eight weeks for GORD, with review of response. Acid-suppressing treatment can be effective; the plan should explain how long to take it and what happens afterwards.

Symptoms that recur can require a step-down approach or longer-term treatment for a valid indication. Maintenance is appropriate for some people. Review the reason for treatment, symptom control and any adverse effects with the prescriber; do not assume that long-term use is always either necessary or harmful.

Lifestyle changes can be chosen according to triggers and the person’s circumstances. Difficulty swallowing, persistent vomiting, bleeding, unintended weight loss or worsening symptoms needs assessment rather than indefinite self-treatment.

What persistent symptoms can mean

Symptoms that do not respond as expected can reflect several possibilities: the diagnosis may need reconsideration, the medicine may need review, or a complication or a different condition may require investigation. Ask whether the dose and timing are correct before assuming treatment has failed.

Gastroscopy is used when indicated to look at the oesophagus, stomach and upper small bowel. A normal test does not mean symptoms are invented, and an abnormal finding still needs clinical interpretation. Treatment and follow-up depend on what is found.

Progressive difficulty swallowing is especially important to report. NICE has a suspected upper gastrointestinal cancer referral pathway for dysphagia; urgent referral is a way to investigate promptly, not proof of a cancer diagnosis.

Understanding upper abdominal discomfort

Dyspepsia is a group of upper abdominal symptoms that can include pain or burning, early fullness and uncomfortable fullness after eating. It overlaps with reflux and nausea. A symptom description alone cannot separate functional dyspepsia from an ulcer or another condition.

Functional dyspepsia is diagnosed when the clinical pattern fits and appropriate assessment does not identify another explanation. The BSG guideline discusses altered sensation, stomach function and gut-brain signalling as possible contributors. The symptoms are genuine even if there is no ulcer visible on gastroscopy.

The assessment takes account of age, medicines, bleeding, weight loss, swallowing problems and other symptoms. The need for endoscopy depends on that context and current referral guidance, not on the word dyspepsia alone.

H. pylori and testing conditions

Helicobacter pylori is a bacterium that can infect the stomach and is associated with peptic ulcer disease. NICE includes a “test and treat” approach for H. pylori in appropriate people with uninvestigated dyspepsia. Not every person with upper abdominal discomfort has this infection.

Breath testing and stool antigen testing are among the methods used to detect active infection. PPI medicines can affect results. NICE specifies a two-week washout after PPI use before a breath test or stool antigen test; follow the testing service’s instructions and ask the prescriber how to manage symptoms during the break.

If infection is found, treatment uses a combination of medicines. Antibiotic choice and further treatment depend on local prescribing guidance, previous exposure and resistance. Ask whether a follow-up test is needed and when to take it; a blood antibody result can be interpreted differently from a test for active infection.

Acid suppression and ulcer risks

For uninvestigated dyspepsia, NICE recommends offering a full-dose PPI for four weeks. The response helps guide follow-up but does not by itself prove the underlying cause. Review persistent symptoms, recurrent symptoms and medicines that could be contributing.

Non-steroidal anti-inflammatory drugs, including ibuprofen and naproxen, can cause stomach irritation and ulcers and increase the risk of bleeding. Risk depends on the person, dose, duration and other medicines. Some people need prescribed protection or a different pain-management approach.

Vomiting blood, coffee-ground vomit or severe sudden abdominal pain can indicate a serious complication and calls for emergency help. Do not wait for a routine H. pylori test if those symptoms occur.

An immune condition with many presentations

Coeliac disease is an immune-mediated condition triggered by gluten in people with genetic susceptibility. Inflammation can damage the small intestinal lining and interfere with absorption. Gluten is found in wheat, barley and rye; the diagnosis is different from a wheat allergy or a self-described food sensitivity.

Diarrhoea, abdominal discomfort and bloating may occur, but a person can present with fatigue, unexplained iron deficiency or other nutrient deficiencies without prominent bowel symptoms. NICE recommends testing in several clinical situations and groups, including persistent unexplained gastrointestinal symptoms and unexplained iron, B12 or folate deficiency.

A symptom response to avoiding gluten does not by itself establish coeliac disease. Diagnosis matters because it changes long-term dietary management, follow-up and consideration of associated problems.

Testing while eating gluten

NICE advises eating some gluten in more than one meal every day for at least six weeks before testing and continuing it through the diagnostic process until a specialist confirms the diagnosis. The initial adult blood tests are total IgA and IgA-tTG, with an IgG-based approach if IgA is deficient.

A negative blood test is not an absolute exclusion if suspicion remains strong. Discuss referral or further assessment with a clinician. If you have already stopped eating gluten, do not start a self-directed challenge without advice, especially if eating it makes you very unwell. Agree the dose, timing and monitoring with the team.

The 2026 BSG guideline discusses a gluten challenge of 3–6 g daily for at least six weeks in the appropriate diagnostic context. This is not an instruction to undertake one alone. Prior test results, symptoms and individual circumstances affect the plan.

Biopsy and the 2026 specialist no-biopsy pathway

NICE recommends referral of adults with positive serology to a gastrointestinal specialist for endoscopic intestinal biopsy. A biopsy takes small samples from the upper small intestine to look for the characteristic changes and help confirm the diagnosis.

The 2026 BSG adult guideline also permits an optional specialist no-biopsy pathway for symptomatic adults whose IgA-tTG is at least ten times the laboratory’s upper limit of normal, with shared decision-making. This is a guideline development alongside the older NICE adult biopsy pathway; eligibility and local specialist practice matter.

Do not interpret a laboratory value without its units, reference limit and the diagnostic context. A high result may prompt specialist discussion; it is not a reason to discard follow-up or assume every adult can bypass biopsy.

After diagnosis

Treatment for confirmed coeliac disease is a lifelong gluten-free diet, supported by a dietitian with expertise in coeliac disease. The practical work includes reading labels, avoiding cross-contact and maintaining a nutritionally adequate diet. Follow-up provides a chance to review symptoms, nutrition and adherence without blame.

If symptoms or deficiencies persist, a clinician can review the original diagnosis, inadvertent gluten exposure, nutritional status and other potential causes. Persistent symptoms do not automatically mean deliberate dietary non-adherence, and they should not be dismissed.

Ask what blood tests and review are appropriate, whether family members should discuss testing, and what to do if symptoms change. Treatment of coeliac disease is more than a short elimination experiment.

Recognising constipation

Constipation may involve fewer bowel movements than usual, hard or lumpy stool, straining, pain or a feeling that the bowel has not emptied. Each person has a usual pattern. A change from that pattern and the effort required to pass stool can be more useful than a single frequency target.

Changes in diet, fluid intake, activity, routine, medicines and underlying illness can contribute. Constipation may also occur with IBS or a problem coordinating the muscles used to pass stool. Several influences can coexist.

A new or persistent change, blood in the stool, unexplained weight loss, regular abdominal pain or a family history of bowel cancer deserves a clinical discussion. Sudden severe pain with inability to pass stool or wind is an emergency.

Treatment depends on the situation

A clinician or pharmacist may suggest changes in fluid, activity, toilet routine and dietary fibre when appropriate. Fibre can help some people but may worsen bloating in others; a gradual, individual approach is more useful than forcing a large increase. For IBS, NICE recommends considering soluble rather than insoluble fibre.

Laxatives work in different ways. Bulk-forming preparations increase stool bulk, osmotic agents draw water into the bowel, and stimulant laxatives encourage bowel movement. Choice depends on stool consistency, symptoms, medical history and the intended duration of use. Ask how to take the product and when to seek review.

Do not keep escalating self-treatment if pain, vomiting, a swollen abdomen or inability to pass wind develops. If constipation persists despite treatment, the diagnosis, medicine list and possible evacuation problem may need review.

Impaction and overflow

Faecal impaction is a build-up of hard stool in the rectum or bowel. Softer stool can leak around it, producing apparent diarrhoea or soiling. This can occur particularly in people with longstanding constipation or reduced mobility, but it should be assessed rather than assumed.

A clinician may use the history and examination to identify impaction and recommend a treatment plan. Simply taking an antidiarrhoeal medicine for leakage without recognising retained stool can miss the underlying problem.

After impaction is treated, prevention and follow-up matter. Review medicines, mobility, hydration, toilet access and the bowel regimen with the care team. New bleeding, weight loss or worsening pain still warrants assessment for other causes.

Short-lived diarrhoea and replacing fluid

Acute diarrhoea and vomiting are often caused by an infection and can improve without specific treatment. The immediate concern is fluid loss. Drink regularly; small, frequent sips can be easier if you feel sick. A pharmacist can advise on oral rehydration solutions, which replace salts as well as water.

Seek urgent advice if you cannot keep fluids down, have bloody diarrhoea, show signs of dehydration despite rehydration, or symptoms are worsening. NHS guidance also advises seeking help if diarrhoea continues beyond seven days or vomiting beyond two days. Severe illness needs earlier attention.

To reduce spread, wash hands with soap and water, avoid preparing food for others where possible, and stay away from work or school until at least 48 hours after diarrhoea and vomiting have stopped. This is infection control, not proof of which organism caused the illness.

Antibiotics and C. difficile

Clostridioides difficile, often called C. difficile or C. diff, is an infection that can cause diarrhoea and colitis. It is particularly relevant after antibiotic use or healthcare exposure, though the history and testing determine whether it is present.

Contact a clinician if diarrhoea follows antibiotics or occurs with a history that raises concern for C. diff, especially when symptoms are significant or persistent. The clinician can decide whether a stool test and treatment are needed. Tell them which antibiotic was taken and when.

Do not routinely take loperamide for suspected or confirmed C. diff; NHS advice says it can prevent the infection clearing. Persistent bloody diarrhoea, dehydration or marked deterioration needs urgent assessment.

When diarrhoea continues

Persistent diarrhoea has a broad differential. Medicines, ongoing infection, coeliac disease, IBS, inflammatory bowel disease, bile acid diarrhoea, microscopic colitis and malabsorption are examples. No one symptom confirms which is responsible.

A history of watery stools at night, weight loss, blood, surgery, relevant medicines or family history can help guide testing. Blood tests, stool tests and, when indicated, endoscopy or targeted tests each answer different questions.

Microscopic colitis can require colon biopsies even when the bowel lining looks normal. If the initial assessment does not explain continuing symptoms, ask what remains possible and when the plan should be reviewed. A label applied early can change as evidence accumulates.

Two conditions, overlapping symptoms

Inflammatory bowel disease, or IBD, includes Crohn’s disease and ulcerative colitis. Both involve inflammation of the digestive tract, but their distribution and clinical patterns differ. Ulcerative colitis affects the colon and rectum; Crohn’s disease can affect different parts of the digestive tract.

Symptoms can include diarrhoea, abdominal pain, urgency, fatigue and weight loss; rectal bleeding is particularly relevant in colitis. Symptoms vary in severity and can overlap with infection or IBS. A diagnosis requires the clinical picture and appropriate investigations, not one symptom alone.

Faecal calprotectin can help identify people who need further assessment for intestinal inflammation, but it cannot name the cause. Infection and other reasons for inflammation must also be considered.

Diagnosis, treatment and monitoring

Specialists use the history, examination, blood and stool tests, endoscopy with biopsies and, where appropriate, imaging to assess suspected IBD. The combination helps establish the type, location and extent of inflammation. Some people require further tests or repeat assessment as the picture develops.

Treatments differ according to whether the person has Crohn’s disease or ulcerative colitis, the site and severity, and previous response. Options can include medicines to reduce inflammation or alter immune activity; some people need surgery. A treatment plan includes monitoring and a discussion of benefits and risks.

The goal is both to control active disease and to support longer-term remission and daily function. Symptoms and inflammation do not always move in perfect parallel, so follow-up may combine symptom review with objective tests when appropriate.

Flares, complications and living with IBD

If you have IBD, ask your team for a written plan covering whom to contact during a flare, which medicines to continue or adjust only under guidance, and when urgent assessment is needed. Increasing diarrhoea, bleeding, pain or inability to maintain fluids can change the urgency.

Severe abdominal pain, major bleeding, collapse or a person becoming seriously unwell requires emergency help. A flare should not be managed indefinitely at home if it is severe or different from your usual pattern.

Living with IBD can also involve fatigue, nutritional concerns and effects beyond the bowel. Report these as part of follow-up. IBS-like symptoms can coexist with IBD, but worsening symptoms should not be presumed functional without assessing the person’s disease and circumstances.

Pouches, symptoms and inflammation

Diverticula are small pouches that can develop in the wall of the large bowel. Having diverticula is called diverticulosis and does not necessarily cause symptoms. Diverticular disease describes symptoms associated with diverticula; acute diverticulitis involves inflammation associated with them.

Abdominal pain, altered bowel habit and bloating can have many explanations. Symptoms that fit diverticular disease still need assessment for other causes when the history suggests them. A scan finding alone does not prove that every symptom comes from the pouches.

Acute diverticulitis can present with persistent abdominal pain, often on the left, with fever or other features. Severity and complications vary. A clinician decides whether blood tests, imaging or hospital assessment are needed.

Treatment is not identical for everyone

NICE recommends that management take account of how unwell the person is and whether complications are suspected. Antibiotics are not automatic for every person with uncomplicated acute diverticulitis; observation without antibiotics can be considered in systemically well people when clinically appropriate.

People who are systemically unwell, immunosuppressed or otherwise at higher risk may need antibiotics, further assessment or hospital care. Do not make this decision from a symptom list alone. Follow the plan given by the treating clinician.

Sudden severe pain, a rigid or very tender abdomen, inability to pass stool or wind with pain, or marked deterioration needs emergency assessment. After recovery, ask what follow-up is appropriate and which new symptoms should prompt earlier review.

Bleeding and longer-term questions

Diverticular bleeding can occur, but visible blood has many possible sources. The amount, colour and associated symptoms help assess urgency, not determine the source with certainty. Major bleeding is an emergency.

NICE recommends considering adequate fluid and dietary fibre for people with diverticular disease, tailored to the individual. A clinician can advise on pain management and review medicines, particularly when there are bleeding or gastrointestinal risks.

A prior diverticular finding should not prevent assessment of persistent bowel change, recurrent bleeding, weight loss or anaemia. These symptoms may need investigation even if a previous episode was attributed to diverticular disease.

Lactose intolerance

Lactose is a sugar found in milk and some dairy foods. Lactase is the enzyme that breaks it down in the small intestine. When lactose is not digested sufficiently, it can reach the colon and contribute to gas, bloating, abdominal discomfort and diarrhoea after ingestion.

Lactose intolerance is not the same as allergy to milk proteins. Symptoms and tolerated amounts differ between people. A clinician may use the history, a planned dietary trial or a hydrogen breath test where appropriate, while considering other explanations for the symptoms.

Lactose intolerance can also follow damage to the small intestine or another condition. If symptoms persist or are accompanied by weight loss, blood or other concerning changes, ask for assessment rather than assuming lactose is the complete answer.

Food allergy and immediate reactions

Food allergy involves an immune reaction to a food. Depending on the type of allergy, symptoms can include skin, gastrointestinal or respiratory problems. A severe reaction, anaphylaxis, is an emergency and can involve breathing difficulty, throat swelling, dizziness or collapse.

If anaphylaxis is suspected, use prescribed emergency adrenaline immediately and call 999, even if symptoms improve. A person with a known allergy should discuss an individual emergency plan, how to use their auto-injector and how to reduce exposure.

Do not deliberately re-expose yourself to a suspected allergy trigger at home to prove a diagnosis. A clinical allergy assessment can consider the history and whether testing or a supervised challenge is appropriate.

Using a food history without losing the bigger picture

Food timing can be a useful clue: record what happened, how quickly, how long it lasted and whether the same pattern recurs. A symptom after a meal is not automatically caused by an ingredient, because normal gut movement and several conditions can also make symptoms more noticeable after eating.

Avoid removing multiple food groups indefinitely without a plan. Restriction can make it harder to maintain adequate nutrition and can interfere with coeliac testing. If you suspect coeliac disease, discuss testing while still eating gluten; if you are already gluten-free, ask how to proceed.

A dietitian or clinician can help choose a focused trial and plan how to interpret it. A severe or immediate reaction needs an allergy pathway rather than an unsupervised elimination and reintroduction experiment.

Symptoms that deserve an explanation

Persistent unexplained bowel change, rectal bleeding, iron deficiency anaemia, weight loss, a palpable mass or swallowing difficulty can have many causes. NICE uses combinations of symptoms, examination findings and age to guide investigations and suspected-cancer referrals.

A suspected-cancer referral means that a serious possibility needs timely investigation. It does not mean cancer has been diagnosed. Equally, a previous benign diagnosis or temporary improvement should not stop a person reporting a new or progressive symptom.

Ask what the next test or referral is intended to assess and how quickly you should hear. If the appointment has not arrived when expected or symptoms change while waiting, contact the service rather than assuming a further step is already in hand.

What a FIT result does and does not mean

NICE recommends FIT for specified symptomatic groups to help guide referral for suspected colorectal cancer. In its pathway, a result of at least 10 micrograms of haemoglobin per gram of faeces triggers referral on a suspected-cancer pathway. A positive result can occur for reasons other than cancer and requires further assessment.

A result below that threshold does not end the assessment when clinical concern remains. NICE advises safety-netting and says referral should not be delayed if there is strong concern, even with a low FIT result or when a sample has not been returned. A rectal mass can prompt referral without waiting for FIT.

FIT is different from a faecal calprotectin test. One detects stool haemoglobin and the other is an inflammation marker; neither alone identifies every cause of symptoms. Ask what result was obtained, what it changes and what to do if symptoms persist.

Upper gastrointestinal and ovarian symptoms

Difficulty swallowing can meet the NICE criteria for a suspected upper gastrointestinal cancer pathway. Persistent vomiting, weight loss or other upper abdominal symptoms also require assessment according to the combinations and ages in current guidance. A referral investigates a possibility; it is not a diagnosis.

Persistent bloating or increased abdominal size, early fullness, pelvic or abdominal pain, and increased urinary urgency or frequency can be relevant to ovarian assessment. These symptoms can overlap with digestive conditions, so describe the whole pattern rather than choosing one body system in advance.

The 2026 NICE ovarian recommendations distinguish age groups. For those aged 39 or under, ultrasound may be considered rather than relying on CA125 alone; from age 40, thresholds depend on age. Follow the current guideline and clinical judgement rather than treating one memorised cutoff as universal.

Gallstones and bile ducts

Gallstones are stones that form in the gallbladder. Many do not cause symptoms, but a stone can block a duct and cause substantial upper abdominal pain. The pain can be central or towards the right and may last for a period rather than appearing only as a brief twinge.

The assessment depends on symptoms and may involve blood tests and ultrasound. A stone seen on a scan is interpreted alongside the history; its presence alone does not necessarily explain every abdominal complaint.

Severe pain, fever or yellowing of the skin or eyes can indicate a complication and needs urgent assessment. Very severe pain or a person becoming seriously unwell warrants emergency help.

Acute pancreatitis and pancreatic enzyme insufficiency

Acute pancreatitis is inflammation of the pancreas that begins suddenly and can be serious. Severe upper abdominal pain, sometimes spreading to the back, with nausea or vomiting needs urgent medical assessment. Gallstones and alcohol are among possible causes; clinical evaluation and investigations establish the diagnosis.

The MHRA advises that people taking GLP-1 receptor agonists or dual GLP-1/GIP medicines should seek urgent medical help for severe persistent abdominal pain, which may radiate to the back, with or without vomiting. Tell the clinician which medicine you take. Pancreatitis is a possibility to assess, not an automatic explanation.

Pancreatic exocrine insufficiency is a different problem in which too little digestive enzyme reaches the gut. It can contribute to malabsorption and greasy stools. Faecal elastase is one test used in context; very watery stool can dilute the sample and give a misleading result.

Delayed stomach emptying

Gastroparesis means the stomach empties more slowly than it should. Symptoms can include feeling full quickly, nausea, vomiting, abdominal discomfort and bloating. These symptoms also occur in other conditions, so a symptom list is not enough to diagnose delayed emptying.

Diabetes, surgery and certain medicines are among factors a clinician may consider. Assessment can include tests to exclude a blockage and a gastric emptying study when appropriate. The choice depends on the history and the need to rule out other causes.

Management is individual and can include dietary advice, treatment of contributing conditions and medicines under clinical supervision. Repeated vomiting, dehydration or inability to keep food or fluid down needs timely review; severe deterioration needs emergency care.

A medicine timeline can reveal a clue

Medicines can affect the digestive tract in different ways. Ask whether a symptom began or changed after a new drug, dose change, antibiotic course or stopping a medicine. Include non-prescription painkillers, supplements and injections, not just repeat prescriptions.

A timing link is useful but not proof. The same person can develop an unrelated condition while taking a medicine. A clinician can weigh the indication, likely adverse effects, interactions and alternatives before deciding what to change.

Do not stop prescribed treatment abruptly without a plan. If a serious reaction is suspected, seek urgent advice and tell the service exactly what you take. New red-flag symptoms need assessment even when a medicine seems a plausible explanation.

NSAIDs, acid suppression and metformin

NSAIDs such as ibuprofen and naproxen can irritate the stomach and cause ulcers or bleeding. People at higher risk may need an alternative or gastroprotection. Vomiting blood or black, sticky stool with abdominal pain needs emergency assessment.

PPIs such as omeprazole reduce stomach acid and have established uses including reflux and ulcer treatment. Review the indication and dose periodically with the prescriber. An association reported in an observational study does not by itself establish that a PPI caused a particular long-term outcome, and selected people need continuing treatment.

Metformin commonly causes gastrointestinal effects such as nausea, abdominal discomfort or diarrhoea, particularly when starting treatment. It can also be associated with vitamin B12 deficiency. A clinician may review the dose, formulation or timing and assess B12 when clinically indicated.

Weight-loss and diabetes injections

GLP-1 receptor agonists and dual GLP-1/GIP medicines can cause gastrointestinal symptoms. Describe the medicine, dose and timing of nausea, vomiting, pain or bowel changes to the prescriber. The same symptoms can arise from other conditions.

The MHRA warns of acute pancreatitis, including severe cases. Severe, persistent abdominal pain, possibly spreading to the back and with or without nausea or vomiting, needs urgent medical help. Tell the clinician that you take one of these medicines.

A medicine review is not a substitute for investigating a serious symptom. Ask the prescribing team what to do with the next dose while you are assessed, and follow the urgent advice you receive.

Pregnancy and the months around birth

Indigestion and heartburn are common in pregnancy. Hormonal changes and the growing baby pressing on the stomach can contribute. A midwife, pharmacist or GP can discuss suitable measures and medicines for the stage of pregnancy.

Do not assume all abdominal pain or vomiting during pregnancy is routine indigestion. Abdominal pain in pregnancy, persistent vomiting, inability to keep fluids down or feeling increasingly unwell needs prompt advice from maternity services, a GP or NHS 111. Severe pain, collapse or other immediately dangerous symptoms need emergency help.

Tell the clinician if you are pregnant, might be pregnant or have recently given birth. This affects the assessment and the choice of investigations and treatments.

Children and older or frail adults

This book is written mainly for adults. Children need age-specific assessment and treatment. NICE guidance on childhood constipation includes assessing for red flags and faecal impaction and arranging appropriate follow-up; a child’s treatment should be agreed with a clinician rather than copied from an adult plan.

In older or frail adults, changes in mobility, access to fluids and toilets, medicines, nutrition and impaction can influence symptoms. Illness may present differently, and dehydration can become important quickly. A new bowel change or weight loss still needs assessment for new pathology.

Carers can help describe a change from the person’s usual pattern, medicine use and fluid intake. Seek advice early if a vulnerable person is deteriorating or cannot drink; severe illness requires emergency help.

Follow-up when the first answer is incomplete

Before ending an appointment, agree who will review results, when they should be available and what happens if they are normal, abnormal or unclear. Ask which possibilities have been addressed and what remains open. A normal test is useful information, not a promise that every possible cause has been excluded.

Track the symptoms that matter to you, the effect of treatment and any unwanted effects. If an intervention helps one problem but another continues, say so. Conditions can coexist, and a plan can be revised as new evidence appears.

Agree the warning signs that require earlier contact. Persistent or worsening symptoms, new bleeding, weight loss, swallowing difficulty or other concerns deserve reassessment. You can ask for an explanation, accessible arrangements or another clinical opinion.

Microbes, microbiota and the microbiome

The digestive tract is home to communities of bacteria, archaea, fungi, viruses and other microorganisms. Microbiota refers to the organisms; microbiome is often used for their collective genes and environment. These communities live alongside the gut lining, food residues and immune cells. They participate in digestion and defence, with effects that depend on context.

Different parts of the tract offer different conditions. Acidity, oxygen, nutrients, mucus and the time material takes to move through the bowel influence which organisms can live there. The dense community in the colon differs from that in the small intestine and next to the lining. Stool is convenient to sample, but cannot capture every location or show everything organisms are doing.

People differ in their microbial communities, and the same person can change over time. There is no agreed universally optimal profile for everyone. Ask whether a claim concerns organisms found, a metabolite measured, a health outcome or a treatment trial. Each answers a different question.

How the community develops

Early life involves major changes in the gut community as infants encounter their environment and feeding changes. In the TEDDY study, researchers followed 903 genetically selected children at increased risk of type 1 diabetes and described stages of microbiome development. Birth and feeding exposures were associated with differences in early communities. The study shows patterns in that group, not a verdict on a particular person's adult health.

Birth circumstances and infant feeding choices are shaped by medical needs and personal circumstances. An association between a feeding pattern and microbes does not prove a parent caused or prevented a later illness. For an adult, the finding does not tell us that a supplement can recreate an early-life community or reverse an illness.

Throughout life, diet, medicines, infections and other circumstances can influence the ecosystem. These influences interact with the host and with one another. A useful question is what can be assessed or changed now, rather than trying to construct a perfect microbial history.

Why good and bad bacteria labels fall short

Some organisms can cause infection, while many normally live in the gut without causing illness. The effect of a microbe can depend on its strain, location, abundance, surrounding community and the person. Describing every named organism as a universal friend or enemy loses those details.

Researchers use dysbiosis to describe an altered microbial community in relation to a comparison. It does not automatically identify a single disease, direction of causation or treatment. An illness can affect diet, bowel transit and medicines, which can also affect a stool profile. Differences may be cause, consequence, a combination or a marker of another factor.

A diversity score describes one feature of a community, not a complete measure of digestive health. More diversity is not automatically better in every body site or circumstance. If a report promises health by raising a score, ask which controlled study tested that recommendation against symptoms or meaningful outcomes.

Fermentation, cross-feeding and short-chain fatty acids

Some carbohydrates resist digestion in the upper gut and reach the colon, where microbes can ferment them. Fermentation produces gases and compounds including the short-chain fatty acids acetate, propionate and butyrate. The amount produced depends on the food, community and conditions in the bowel. Fermentation is normal, although gas and distension can be uncomfortable.

Microbes can share products of their metabolism. In cross-feeding, one organism uses a substance another has released. Butyrate is an energy source for cells lining the colon and has other studied roles, yet a pathway on a diagram does not prove that a particular butyrate supplement will treat an individual's symptoms.

Beans, oats, vegetables and whole grains provide different fermentable materials, but the amount a person tolerates varies. Introduce changes gradually if symptoms flare, while preserving adequate energy and variety. A gas response on its own does not establish damage or infection.

Competition, immune defences and medicines

An established community can make it harder for some incoming organisms to establish themselves, through competition for nutrients and space and through the substances it produces. This is called colonisation resistance. It is one part of a larger defence that also includes stomach acidity, bowel movement, the lining and immunity.

Gut microbes and the immune system communicate throughout life. The community helps shape immune responses, while host defences help control contact with microbes. Finding a difference between patients and controls does not show which change came first or establish an effective immune treatment.

Medicines, including antibiotics, can affect the gut community. Antibiotics are sometimes essential and should be taken as prescribed; a change in a microbiome report is not a reason to stop a needed course. If diarrhoea develops during or after treatment, discuss its severity and timing with a clinician rather than assuming every episode has the same cause.

The difference between presence and function

A test may identify genetic material from organisms in a sample. That can be informative for research, but finding a name or gene does not directly measure the organism's activity, the amount of a metabolite reaching a tissue or the effect on a symptom. An organism can have the capacity for a process without performing it at a fixed rate.

Research also measures metabolites and gene expression, but collection, storage and analytical methods affect results. Even a real difference in a compound needs context: diet, medication, bowel transit and the site sampled can all matter. Individual treatment thresholds require clinical validation, not just a colourful chart.

When a product promises to raise a named bacterium, ask what happens to people rather than only to the number. Was the exact product compared with a control, in a similar group, with useful outcomes and harms recorded? Changing a measurement and improving an illness are separate findings.

Nerves, hormones and immune signals

The gut and brain communicate in both directions through nerves, hormones, immune signalling and other pathways. The enteric nervous system coordinates much local digestive activity, while the central nervous system responds to signals from the gut and influences movement and sensation. A meal, pain, sleep or a stressful event can enter this conversation in different ways.

In disorders of gut-brain interaction such as IBS, altered bowel movement and sensitivity can contribute to pain and changes in stool. The experience is physical and can be disruptive even when routine tests do not show inflammation or structural disease. An individual can also have another condition, so a changing pattern deserves assessment.

Research into microbial contributions to brain signalling is active. Many mechanisms are clearer in experimental models than in humans. An association between a stool profile and mood or symptoms does not establish that microbes caused those experiences or that a commercial product will change them.

A sensitive gut and the reality of pain

People with IBS may experience discomfort with an amount of gas or stretching that another person barely notices. Increased sensitivity is one possible mechanism and can coexist with constipation, diarrhoea or visible distension. A symptom influenced by nerve signalling is still real and worthy of treatment.

NICE and the British Society of Gastroenterology describe ways to manage IBS, including dietary advice, medicines and, for some people, gut-directed psychological therapies. Choice depends on symptoms, access, preferences and other needs. These approaches do not replace investigation of warning signs or reconsideration when the picture changes.

Ask what is being treated, how success will be judged and when the plan will be reviewed. Reducing pain or enabling a journey without urgent toilet stops are meaningful outcomes even if a stool report stays the same.

Stress, sleep and practical support

A difficult day, disrupted sleep or worry about finding a toilet may coincide with gut symptoms. The relationship can go both ways: discomfort can disturb sleep and make work, eating or social plans more stressful. These observations can help identify support without assigning blame for an illness.

A realistic plan might include predictable meal opportunities, access to a toilet or support with a stressful work pattern. Some people choose gut-directed psychological treatment alongside medical assessment and nutrition support. It should be offered with a clear explanation, without implying symptoms are imagined.

Keep a short note of sleep and major changes alongside symptoms if it helps. Timing alone does not prove cause. If tracking increases anxiety or restricts life, reduce it to information useful for an appointment or agreed review.

Mucus, cells and immune defences

The intestinal barrier is a system rather than a solid wall. Mucus helps separate intestinal contents from the surface; epithelial cells form a lining; junctions between cells regulate passage; and immune defences respond to what reaches them. The barrier also has to allow useful absorption of water and nutrients. Its activity differs along the gut.

Permeability describes how readily substances pass through a barrier under particular conditions. Researchers can study it with different tests and probes. Changes can accompany recognised illnesses, but a changed research measure does not identify one universal cause for unrelated symptoms or establish a standard diagnosis called leaky gut syndrome.

Someone with ongoing symptoms deserves assessment for relevant conditions and care for the symptoms themselves. A diagram of a widened junction cannot identify the cause in that person or show that a purchased treatment has repaired it.

Zonulin tests and commercial interpretations

Zonulin is discussed in research on intestinal permeability, but commercial assays and interpretation of an isolated result have important limitations. A coloured range is not proof that a disease, food intolerance or exposure has been diagnosed. Ask what the specific assay measures, how reliably it does so and whether its interpretation has been validated for the proposed decision.

A recognised condition in which barrier function is investigated differs from a package claiming to explain fatigue, pain and digestive symptoms with one number. Before buying a test, ask what would change if the result were high, low or normal, and whether that action has improved outcomes in controlled studies.

If a long restrictive diet or supplement plan is proposed from an isolated result, discuss nutritional adequacy, cost, adverse effects and what else may need assessment. A normal commercial result does not by itself explain away continuing symptoms either.

Glutamine: a promising trial with a defined population

Glutamine is an amino acid studied in intestinal biology. In a randomised trial in a selected group with post-infectious IBS with diarrhoea and increased intestinal permeability, 106 people completed the study. The reported primary response was 79.6% with glutamine versus 5.8% with placebo. This is a striking result for that study population.

The trial does not establish that glutamine repairs every person's gut, works in all IBS subtypes or treats any illness associated with a commercial permeability result. Its eligibility criteria, intervention and follow-up matter. Further independent evidence and assessment of safety in different groups help determine how widely the result can be applied.

Before taking a supplement, ask a clinician or pharmacist whether it fits your diagnosis, medicines and circumstances, the intended dose and duration, possible adverse effects and what outcome will be reviewed. A response can be useful information but does not by itself identify the underlying cause.

Adequacy comes before a perfect food list

When eating is followed by pain, urgency or bloating, food can become a source of anxiety. The first practical question is whether a person can eat enough, drink enough and maintain a pattern they can live with. Unintended weight loss, persistent restriction or difficulty meeting needs deserves dietetic and medical assessment. Body size alone does not establish whether intake is adequate.

A useful starting point is a range of affordable foods that the person tolerates, with sources of carbohydrate, protein and fat as well as fruit, vegetables or other suitable sources of micronutrients and fibre. Frozen, tinned and dried foods can be useful. Culture, allergies, budget, facilities and the energy needed to prepare food all shape a workable plan.

A person with active inflammatory bowel disease, previous surgery, a narrowing or malabsorption may need different advice from general population guidance. Ask the treating team what to adjust and for how long. Adding rules to an already inadequate diet can make eating harder without addressing the cause.

Regularity without rigidity

NICE IBS advice includes making time for meals and avoiding long gaps between eating. For some people, smaller regular meals or a calmer eating setting are practical ways to reduce uncertainty. Preferences and schedules vary, and no single pattern is guaranteed to resolve symptoms.

Notice whether a large meal, a particular drink or a long gap is followed by a consistent pattern. Bring observations to an appointment rather than removing a large group of foods after one bad day. A meal contains many ingredients and symptoms may be delayed or vary for reasons unrelated to that meal.

There is room for pleasure and social eating in a care plan. If the only way to follow a suggested protocol is to skip meals, spend beyond your means or avoid family occasions, discuss a less burdensome option. Evidence has to be used in the life of the person eating the food.

Mediterranean-style advice in an IBS trial

A 2025 UK randomised trial enrolled 139 people with IBS and compared Mediterranean diet advice with traditional dietary advice. At six weeks, 62% in the Mediterranean advice group and 42% in the traditional advice group reported the trial's symptom response. This is a useful positive finding, not proof of a cure or of benefit for every individual.

A Mediterranean-style pattern can include varied plant foods, olive oil and other foods adapted to preference and tolerance. It does not require expensive imported products or a single rigid menu. Beans, vegetables and whole grains can also trigger symptoms for some people, so quantities and preparation may need adjustment.

The trial measured an outcome at six weeks; it cannot on its own establish long-term symptom control or identify which component made the difference. A dietitian can help adapt a pattern to the person's needs and assess whether it provides enough food. Compare improvements in daily life as well as any change in a score.

What fibre does and where to find it

Fibre is a broad group of plant components that resist digestion in the small intestine. Different fibres behave differently: some hold water or form a gel, some add bulk, and some are readily fermented by gut microbes. Many foods contain a mixture. The effect depends on the type, amount and individual.

The NHS recommends that adults aim for 30 grams of fibre a day. Wholegrain or higher-fibre bread, oats, beans, lentils, fruit, vegetables, nuts and seeds can contribute. Use foods you can afford and tolerate. This population target is not an instruction to force more fibre during a suspected obstruction or when a clinical team has advised differently.

Increase gradually when possible, and maintain suitable fluid intake. A sudden large increase can bring wind and discomfort. If symptoms or a medical condition limit fibre, ask a registered dietitian how to meet nutrition needs and which forms or amounts are appropriate instead of pushing through worsening symptoms.

Constipation: the trial evidence

A meta-analysis of 16 trials involving 1,251 adults examined fibre supplementation in chronic constipation. In pooled data, response was 66% with fibre compared with 41% in controls, with a relative risk of 1.48. The studies varied in fibre type, dose, duration and participants, and flatulence was more frequent. The pooled result is an average across studies, not a prediction for one person.

Psyllium, also called ispaghula, has evidence for constipation, but individual response and tolerance vary. Follow product instructions and seek advice about adequate fluids and medicine timing. Fibre is not the only question: medicines, eating and drinking, activity, pelvic floor problems and other conditions can be relevant.

If constipation is persistent, new or accompanied by concerning changes, discuss it with a clinician rather than escalating fibre indefinitely. Sudden severe pain, or inability to pass stool or wind, requires emergency help: call 999 or go to A&E. A clinician can assess whether a laxative, investigation or another approach is appropriate.

IBS: soluble fibre and individual tolerance

The British Society of Gastroenterology recommends soluble fibre such as ispaghula for IBS, introduced gradually because it can cause bloating. Insoluble fibre such as bran may worsen symptoms in some people. Whole foods contain mixtures of fibre, and this is not a rule that everyone must avoid every food containing bran.

A practical change might be a small amount of oats or a clinician-advised soluble fibre preparation, increased slowly while monitoring stool form, pain and wind. A preparation's dose and formulation differ from a portion of food. If a change makes symptoms or eating worse, discuss a different approach.

Low fibre intake may coexist with diarrhoea, constipation or alternating symptoms. The aim is a tolerable pattern that supports adequate nutrition, not a race to a number. With complex medical conditions or a severely restricted diet, individual advice is particularly important.

Why a meal can produce symptoms

Symptoms after food have several possible explanations. A meal can stretch the stomach, trigger normal bowel movement, contain poorly absorbed carbohydrates or coincide with symptoms that were already developing. Food allergy, coeliac disease and other conditions have distinct mechanisms and assessment pathways. Timing is a clue, not a diagnosis.

FODMAP is a group name for fermentable oligosaccharides, disaccharides, monosaccharides and polyols. Some are poorly absorbed in the small intestine, can draw water into the bowel and can be fermented by microbes. In susceptible people these effects may contribute to gas, distension, pain or stool changes. The same foods may be nutritious and well tolerated by someone else.

A symptom response to changing these carbohydrates does not prove intestinal damage, a specific infection or that every food in the group must be avoided permanently. Assessment should consider the person's diagnosis, eating pattern, medication and signs that need further investigation.

Three phases, not a permanent exclusion list

The BSG describes a low FODMAP diet as a second-line dietary approach for IBS, preferably supervised by a dietitian with relevant expertise. It usually begins with a temporary reduction, followed by structured reintroduction and a personalised long-term diet. The goal is a tolerable pattern, not keeping every FODMAP food out indefinitely.

The dietitian can check the starting diet and help select substitutes before restriction begins. Reintroduction then tests groups in an organised way, using a plan appropriate to the person. Quantity matters: a food may be tolerated in one portion and troublesome in a larger one. Other day-to-day variation can complicate interpretation.

If there is no meaningful benefit, the diet should not simply become more restrictive. Review the diagnosis, adherence, other options and nutritional impact with the clinician. A person already struggling to eat enough, with an eating disorder history or complex medical needs may need a different or more carefully supported plan.

A food diary as a question, not a verdict

For a short agreed period, note roughly what and when you eat, stool form and urgency, pain or bloating, sleep, stress, menstrual-cycle changes where relevant, medicines and treatments. A brief description is often more useful than weighing every ingredient. Include better days as well as difficult ones, and record anything else that changed.

Look for patterns that recur and can be discussed, rather than treating every symptom following a food as proof of a trigger. A delayed response, a mixed meal or natural fluctuation makes attribution difficult. A clinician or dietitian can help decide whether a measured change and reintroduction would answer a useful question.

Set a stopping point for the diary and keep the task proportionate. Tracking should not turn meals into a test of self-control or delay assessment when symptoms change. Ask what else might explain the pattern and how to make sure you can still eat enough.

What a fermented food study showed

Fermentation uses microorganisms to transform food. Examples include some live yoghurts and fermented vegetables, although preparation and storage differ and not every fermented product contains live microbes when eaten. Foods may also differ in salt, sugar, alcohol and other ingredients. An enjoyable food does not need to be sold as a medical treatment to have a place in a diet.

In a small randomised dietary study, 36 healthy adults followed a high-fermented-food or high-fibre intervention. The fermented-food group showed increased microbial diversity and reductions in some measured inflammatory markers. This provides a reason for further investigation, not proof that fermented foods treat IBS, IBD or a specific person's inflammation.

If trying a fermented food, choose one you like and tolerate and start with an ordinary portion. Check ingredients against allergies, dietary needs and any clinical advice. Bloating or discomfort is a reason to adjust or stop, not evidence that a painful cleanse is necessary.

Prebiotics: food for selected microbes

A prebiotic is a substrate selectively used by host microorganisms that confers a health benefit. Some fibres and other food components are studied for prebiotic effects, but not all fibre is interchangeable and a product's effect depends on its composition, amount and the person. A list of bacteria that can use an ingredient does not show which symptom it will improve.

Fermentation can generate gas. Concentrated prebiotic powders or large sudden increases in fermentable foods may be uncomfortable for someone with IBS. Introduce foods gradually where appropriate. A person on a temporary low FODMAP plan can work with a dietitian to maintain as much suitable variety as possible.

Ask what the exact ingredient was tested for, at what dose and in whom. A claimed change in microbial abundance is different from measured improvement in pain, stool or daily function. If the product is costly or makes symptoms worse, that is relevant to the decision to continue.

Practical variety without a numerical target

Different plant foods supply different fibres and nutrients. A varied intake can be built from ordinary staples such as oats, potatoes, rice, vegetables, fruit, pulses, nuts and seeds according to tolerance. Frozen vegetables, tinned beans and seasonal choices can reduce cost and preparation time. There is no need to buy a proprietary mixture to make a meal varied.

Counting plant foods in a week can be a personal way to notice variety, but should not become a diagnostic score or a pressure to eat foods that cause significant symptoms. With narrowing, active illness or a medically prescribed restriction, follow the individual plan and ask when it should be reviewed.

Preparation and portion can matter to comfort and convenience. Try a small change at a time, keep enough reliable foods in the plan and record meaningful effects. If variety has narrowed substantially, a dietitian can help restore foods safely where appropriate and consider nutrient risks.

Strain, dose, purpose and person

Probiotics are live microorganisms that, when administered in adequate amounts, confer a health benefit on the host. Products differ in organism, strain, combination, dose, formulation and handling. Evidence for one product in one population does not automatically transfer to another product or condition. A larger number of organisms on a label is not proof of better clinical results.

For IBS, NICE advises people who choose a probiotic to take it for at least four weeks at the manufacturer's recommended dose while monitoring the effect. BSG suggests a trial of up to 12 weeks and stopping if there is no improvement, while rating the evidence very low and identifying no preferred species or strain. The American Gastroenterological Association recommends probiotics for IBS only in the context of a clinical trial. These guidance positions differ.

The disagreement reflects differences in evidence assessment and recommendations, not proof that all probiotics work or none ever can. Ask what outcome the specific product was studied for, how long a trial should last, how much it costs and what would count as worthwhile improvement. Check with a clinician before use if seriously ill, immunocompromised or managing a complex condition.

Antibiotic-associated diarrhoea: what the pooled trials found

A systematic review of 42 trials involving 11,305 adults examined probiotics for prevention of antibiotic-associated diarrhoea. The pooled relative risk was 0.63 compared with controls, with moderate-certainty evidence. The estimated benefit was not shown in settings with a low baseline risk, and formulations and studies varied. The relative effect does not tell an individual their absolute likelihood of benefit without knowing their starting risk.

This evidence concerns prevention in the trial settings, not proof that any probiotic treats existing diarrhoea or prevents every case of Clostridioides difficile infection. It does not establish that all products, doses or populations are equivalent. A clinician can consider a person's illness, infection risk and treatment circumstances.

If diarrhoea develops during or after antibiotics, report persistent, severe or worsening symptoms and relevant medicines. Do not stop a prescribed antibiotic or replace assessment with a supplement without advice. A product should not delay care when infection or dehydration is a concern.

Planning and reviewing a trial

Record the exact name and strain if given, daily amount, start date, price and intended symptom. Choose an outcome that matters, such as the number of urgent journeys to the toilet, pain severity or ability to eat a meal comfortably. Keep other non-urgent changes stable where practical so the result is easier to interpret.

Symptoms fluctuate and expectation can influence an experience. A better week after starting a product may be welcome without proving a microbial mechanism. A worse response is also useful information. Agree when to review and stop, and check whether a different preparation is genuinely supported by evidence rather than merely more expensive.

Supplements can have unwanted effects and may be unsuitable for some people. A pharmacist or clinician can consider medical conditions and the full medicine and supplement list. Avoid presenting any live product as a substitute for prescribed treatment of a diagnosed condition.

Food allergy and food intolerance

Food allergy involves an immune response to a food and can cause symptoms affecting the skin, breathing, circulation or digestive tract. Some reactions can be severe and life-threatening. Food intolerance can cause discomfort through different mechanisms and does not mean the same thing as an allergy. A symptom after a food does not on its own distinguish them.

If a suspected food reaction involves swelling of the tongue or throat, breathing difficulty, collapse or other signs of anaphylaxis, use prescribed emergency adrenaline immediately and call 999, even if symptoms improve. Do not deliberately eat the suspected food to test a possible serious allergy at home. A clinical history and appropriate assessment guide the next step.

For less immediate symptoms, record what was eaten, the amount, timing and symptoms, then ask a clinician whether allergy, intolerance or another explanation is plausible. Restricting several foods without a plan can reduce dietary adequacy while leaving the original question unanswered.

Coeliac testing before removing gluten

Coeliac disease is an immune-mediated condition triggered by gluten in genetically susceptible people. Testing is more reliable while gluten is still being eaten. NICE recommends gluten in more than one meal every day for at least six weeks before testing, and continued gluten during the diagnostic process. Ask for clinical advice before changing the diet.

For adults and young people, NICE recommends total IgA and IgA tissue transglutaminase, or IgA tTG, as the first serological tests. The clinician interprets the result and any IgA deficiency and decides whether further tests or specialist referral are appropriate. Blood tests are part of a diagnostic pathway, not the whole story in every case.

If you have already stopped eating gluten, discuss a safe and appropriate testing plan with your clinician rather than guessing how to restart it. Symptoms that seem related to wheat also have other possible explanations. A short-lived improvement after eliminating a food does not by itself establish coeliac disease or identify the responsible ingredient.

Histamine claims and limits

Histamine is involved in normal body processes and can be present in foods. People may report symptoms they connect with particular foods, but the guideline on suspected adverse reactions to ingested histamine describes inconsistent evidence and difficulty establishing a reliable diagnosis. These symptoms can overlap with allergy, gut disorders and many other conditions.

The guideline does not support interpreting serum diamine oxidase, or DAO, as a reliable stand-alone diagnostic test for histamine intolerance. A low result from a commercial package cannot by itself identify the cause of symptoms or establish that a DAO supplement will treat them. A history and consideration of other explanations remain important.

Avoid removing a long list of foods indefinitely on the basis of one result or a generic online list. Where a clinician and dietitian consider a food-related trial appropriate, agree its scope, time limit, nutritional substitutes and reintroduction plan. Possible serious allergic reactions need their own assessment rather than a histamine label.

What the IBS-specific study tested

A randomised study of an IBS-specific IgG ELISA-based elimination diet enrolled 238 people, with 223 in the modified intention-to-treat analysis. At eight weeks, abdominal pain response was reported in 59.6% of the active-diet group versus 42.1% of the control group. The trial is a real positive result for the specific assay, diet and population studied.

It does not establish that every commercial food IgG panel is valid, that IgG identifies a food allergy, or that all foods with an elevated result need lifelong exclusion. The study's outcome, eligibility, comparison and relatively short follow-up matter. Its funding and conflicts were not fully appraised for this guide, and its findings need to be considered alongside further independent evidence.

An elimination diet can change many features of eating at once. A symptom response does not prove the antibody caused the symptom or establish a durable benefit for each removed food. Ask whether the exact test and intervention offered are the ones studied and how an individual food will be reintroduced and assessed.

From laboratory result to a meal

A laboratory report can identify a measured antibody response without proving that the food causes symptoms. In particular, the IBS trial is not a basis for using a broad IgG panel to diagnose a food allergy. Allergy assessment follows a different clinical pathway and depends on the type of reaction and appropriate tests.

Before purchasing a panel, ask what condition it is intended to assess, whether its accuracy and treatment decisions have been validated, and what happens if it labels foods that you regularly rely on. Request the full cost of testing, consultation, supplements and repeat testing. A high number of reported sensitivities can make the resulting diet difficult to sustain.

Discuss any proposed exclusion with a dietitian, especially if intake is already limited. Agree a time limit, replacements that supply comparable nutrients, an outcome to measure and a reintroduction plan. Long-term nutritional safety of broad panel-led elimination was not established by the short IBS trial.

A result deserves context, not a rulebook

If symptoms improve during an elimination period, record the improvement and review what changed. Food choices, portion sizes, meal timing, stress and other treatments may have shifted together. Reintroduction under appropriate guidance can help examine whether the improvement persists and whether an individual food is consistently associated with symptoms.

If the trial does not help, adding another set of exclusions is not automatically the answer. Revisit the working diagnosis, alternative treatments and the burden of the diet. Ask for help restoring variety rather than accepting a progressively shorter food list as evidence of progress.

A controlled positive trial should be neither dismissed nor expanded beyond what it tested. Its findings can inform a discussion while recognising that individual decisions require attention to the exact intervention, potential harms, cost and nutritional needs.

A recognised problem with an uncertain boundary

Small intestinal bacterial overgrowth, or SIBO, refers to an excess or altered pattern of bacteria in the small intestine. It is recognised in some clinical settings, including altered anatomy, impaired movement or stasis and malabsorption. Symptoms can include bloating and bowel changes, but they overlap with other conditions and do not identify SIBO by themselves.

The American Gastroenterological Association notes uncertainty about the definition of SIBO and limited evidence to guide antibiotic treatment. A relevant medical history, nutritional consequences and possible underlying reasons for stasis or altered anatomy matter. A person can have genuine symptoms without having one particular explanation.

If a practitioner suggests SIBO, ask which features make it likely in your case, which other conditions could fit and whether the proposed test will change care. Clarify how a diagnosis would be followed up, including nutrition and any underlying condition.

Breath tests, transit and disagreement

Breath tests measure gases after a person consumes a test sugar. Preparation, the substrate, timing, sample collection and how a result is interpreted all matter. A positive result is not a direct count of organisms in every part of the small bowel, and test performance and clinical use remain contested.

An ESNM and ANMS clinical practice update criticises routine breath-test-based SIBO diagnosis in IBS. It explains that lactulose breath findings can reflect the speed of transit to the colon, rather than reliably identifying small intestinal overgrowth. This critique is especially relevant when a report claims a positive test proves SIBO is the cause of IBS.

Ask which substrate and criteria the laboratory used, how the result relates to your history and how false-positive or false-negative results are considered. A negative test does not mean symptoms are imagined; a positive test does not remove the need to consider other explanations.

Treatment response does not prove the diagnosis

Antibiotics may be used in selected patients, but treatment evidence and the definition of the condition have limitations. Antibiotics have possible adverse effects and consequences, and the reason for an ongoing problem may also need attention. A temporary improvement after antibiotics is not by itself proof that SIBO caused the symptoms.

Repeated courses, multiple supplements or a restrictive diet can carry costs and risks. Ask what benefit is expected, what harm is possible, what alternatives exist and whether a defined review is planned. If a provider proposes treatment for a long time, ask how recurrence is being assessed and what would lead the team to reconsider the diagnosis.

Keep the GP or treating specialist informed of prescriptions and supplements, including those obtained privately. A clinical plan should protect adequate food intake and address significant weight change or malabsorption while the underlying question is assessed.

A consumer profile is not a clinical diagnosis

An international consensus published in 2025 discourages routine use of direct-to-consumer microbiome profiling for clinical decisions. Results depend on diet, medicines, bowel transit, sample collection and laboratory methods. One sample represents a moment and cannot map the entire digestive tract. The authors do not identify an established universal healthy range that applies to every person.

A report may show a Firmicutes-to-Bacteroidetes ratio, a dysbiosis index or a diversity score. These numbers are not validated stand-alone guides to an individual treatment plan. They cannot establish what every microbe is doing or which disease caused a symptom. Comparing reports from different laboratories is also difficult when methods differ.

Before buying, ask what the test can reliably measure, which clinical decision it changes, whether the recommendations were tested against health outcomes and who will interpret uncertain results. Check whether the provider also earns money from products recommended after the report.

Clinical stool investigations answer different questions

A clinician may request a stool investigation for a specific question, such as evidence relevant to infection, inflammation or digestive function. The choice depends on symptoms, history and examination. These focused investigations differ from a commercial profile that ranks large numbers of organisms against a proprietary wellness score.

An appropriate test has a reason, a specimen requirement and a plan for interpreting and following up the result. Ask what a positive or negative result would mean, what might affect accuracy and who will tell you what happens next. A result may need to be read alongside blood tests, clinical findings or specialist assessment.

Do not assume that ordering more markers always yields a more useful answer. Additional results can bring uncertainty, expense and unnecessary treatment. Equally, a person whose initial tests are normal can still need symptom care and a review if their condition changes.

Taxonomy, function and sales recommendations

A list of organisms is called a taxonomic profile. It can describe what was detected in a sample with a particular method, but it does not directly establish metabolic activity throughout the gut. An inference that a named organism makes a specific amount of a metabolite for one person needs its own measurement and clinical validation.

A report may connect a low or high score to a personalised supplement package. Ask for evidence that the entire test-and-treatment pathway improved a meaningful outcome compared with care without the package. A study showing that a product changes a bacterium does not establish that it improves the person's symptoms.

If you already have a report, take it and the complete supplement list to an appointment. Explain what you hoped it would answer and which symptoms remain. A clinician can help separate established investigations from exploratory claims and agree what deserves attention next.

Inflammation, symptoms and nutrition

Inflammatory bowel disease includes Crohn's disease and ulcerative colitis. Nutrition matters both because illness can affect appetite, absorption and nutritional status and because some dietary strategies have been studied as part of treatment. The choice depends on the disease, its activity and location, complications and the person's care plan.

Symptoms and inflammation do not always move together. Someone may have pain or altered stool while inflammatory disease is in remission, and someone may have active inflammation without symptoms that accurately reflect its extent. A dietary change that reduces bloating does not by itself prove that inflammation has healed.

Ask the IBD team which measures they use to assess disease activity, whether a dietitian is available and how nutrition will be monitored. Continue prescribed treatment unless the prescribing clinician advises a change. Food choices can complement a treatment plan without replacing monitoring of the underlying disease.

Crohn’s disease: specialist nutritional therapies

The European Crohn's and Colitis Organisation consensus discusses exclusive enteral nutrition, in which a prescribed liquid nutritional formula is the sole source of nutrition for a defined period, as a treatment option in Crohn's disease under specialist care. It also considers a Crohn's disease exclusion diet combined with partial enteral nutrition for selected patients. These are structured medical approaches, not interchangeable wellness detox diets.

Suitability depends on age, disease features, goals, preferences and specialist assessment. A formula plan needs adequate energy and nutrients, clear instructions, monitoring and a plan for what comes next. A diet sold online under a similar name should not be assumed to have the same composition or evidence.

Ask the treating team what outcome is intended, how disease activity and nutritional status will be checked, and what happens if the diet is intolerable or ineffective. If a person has narrowing or obstruction risk, advice about food texture and fibre must be individualised.

Ulcerative colitis and maintenance choices

The ECCO consensus does not recommend a specific diet for inducing remission in ulcerative colitis. It suggests a Mediterranean dietary pattern may be considered as an adjunct during maintenance. This is different from claiming that a general food list can replace medication or reliably switch off active inflammation.

A low FODMAP approach may help symptoms in selected people, including some whose IBD is in remission, but symptom improvement does not establish inflammatory remission. The plan should be time-limited, followed by reintroduction and adapted to the person's nutritional and medical needs.

If food avoidance is growing or weight is falling, seek dietetic and medical support. Ask how to distinguish a symptom-management goal from a disease-control goal, what monitoring is due and whom to contact if the pattern changes.

Pancreatic enzymes are a prescribed treatment

The pancreas supplies digestive enzymes that help break down food. In exocrine pancreatic insufficiency, inadequate enzyme delivery can contribute to maldigestion, weight loss and nutritional problems. The AGA advises assessment according to clinical context, including risk factors and appropriate testing. Symptoms overlap with other digestive conditions.

For diagnosed exocrine pancreatic insufficiency, pancreatic enzyme replacement therapy is prescribed and taken with meals as directed. The clinical team can review dosing, response, nutritional status and any need for further investigation. A non-prescription digestive enzyme blend is not automatically equivalent to prescribed pancreatic replacement.

A temporary response to enzymes alone is unreliable for diagnosing pancreatic insufficiency. Ask what test or clinical evidence supports the diagnosis, how the prescription should be taken and how nutritional needs will be monitored. Do not stop prescribed replacement based on a supplement advertisement.

Faecal microbiota transplant and recurrent C. difficile

Faecal microbiota transplant, or FMT, transfers processed donor stool material to a recipient as a medical treatment. NICE recommends it as an option for eligible people with recurrent C. difficile infection who have had two or more previous confirmed episodes, after antibiotic treatment. The recommendation applies to this defined circumstance, not all digestive symptoms.

Clinical pathways use screened donor material, processing and monitoring to reduce risks. Infection transmission remains a serious concern. Do not attempt a do-it-yourself transplant or use unscreened donor material. If recurrent C. difficile is suspected, ask the clinical team about confirmation, treatment and eligibility for specialist options.

Studies of microbiota-based treatments in other conditions are important research, but the existence of one established indication does not prove effectiveness for IBS, fatigue or a commercial dysbiosis score. Ask what trial evidence and regulated clinical pathway apply to the precise condition and product being offered.

Matching an intervention to its evidence

An intervention can be valuable for a defined indication without being useful for everyone with bloating. Prescribed enzyme replacement addresses a documented pancreatic problem; FMT has a specific NICE recommendation for recurrent C. difficile. An IBS dietitian may instead address meal patterns and a time-limited dietary trial. The diagnosis and outcome determine which evidence is relevant.

Ask what the treatment is intended to change: nutrient absorption, confirmed infection, pain, stool frequency or disease activity. Different outcomes need different methods of assessment. Feeling better matters, but it cannot on its own verify a claimed mechanism or guarantee that another condition has resolved.

Bring a list of prescribed treatments, over-the-counter preparations and supplements to appointments. Discuss the practical burden, total cost and follow-up plan, and agree what should trigger an earlier review. Do not replace an established treatment without discussing it with the clinician responsible for it.

An emulsifier experiment and its limits

Emulsifiers are ingredients used to help maintain mixtures and texture in some foods. In a controlled feeding study, 16 healthy adults received diets with or without 15 grams a day of carboxymethylcellulose for 11 days. The researchers reported changes in the gut microbiome and metabolites and greater post-meal abdominal discomfort in the exposed group. This is a useful human experimental finding.

The study tested one emulsifier at a specified amount for a short period in a small group. It does not prove that every emulsifier causes illness, that all ordinary dietary exposures have the same effect, or that a change in a microbiome measure will lead to long-term disease. Different ingredients and amounts require their own evidence.

Someone who notices a pattern with a product can compare its ingredients, portions and timing and discuss it with a dietitian. Preserve adequate affordable foods while considering changes. A label saying processed does not by itself tell you whether one particular food caused a symptom.

Exposure questions need specific evidence

A useful exposure history names the suspected substance or condition, place, timing and route of exposure, rather than relying on a general label such as toxic burden. A clinician can consider the symptoms, possible sources and whether a validated test or relevant environmental assessment exists. An association or an online questionnaire is not a measurement of a person's exposure.

The targeted evidence reviewed for this book does not establish that broad commercial toxin panels, electromagnetic-field claims or binders diagnose or treat unexplained digestive symptoms. That is a limit of this research, not a claim that all exposures are harmless. Ask which specific exposure is suspected, what the test measures and how a result would change management.

If there is a concrete hazard at home or work, address immediate safety through the appropriate service and seek medical advice. Avoid deliberately re-exposing yourself to test a theory. A stool profile or a symptom diary cannot independently identify an environmental cause.

Cleanses, binders and the body’s normal processes

The body has established ways to process and eliminate substances, including functions of the liver, kidneys and digestive tract. The existence of these processes does not establish that a marketed detox programme removes a particular harmful substance or improves symptoms in a person without a diagnosed exposure.

NCCIH notes limited evidence for detoxes and cleanses and describes potential harms, including dehydration and electrolyte disturbances from some regimens. Restrictive plans can make adequate intake harder. The claimed appearance of material after a cleanse is not a reliable diagnosis of an infection or toxin burden.

Before taking binders, herbs or laxative products, ask a pharmacist or clinician about ingredients, interactions, safety, cost and the proposed end point. Do not replace needed food, prescribed medicines or investigation with a cleanse. Ask what evidence shows that the exact intervention improves a relevant outcome in people like you.

NHS and functional-health perspectives

Some functional-health practitioners place particular emphasis on food, sleep, stress, exposures and extended tests. NHS care can also consider the whole person, symptom patterns, nutrition and psychological support. Training, access and proposed investigations vary between individuals and services; neither a job title nor a style of consultation validates every test or recommendation.

Compare a proposal by its question, supporting evidence, likely benefit, potential harm, cost and review point. A carefully chosen dietary trial, appropriate clinical investigation and symptom treatment can coexist. An elaborate pathway chart is most useful when its claims are separated into established biology, associations and results from interventions.

If a person has felt dismissed, the priority is a respectful assessment and a plan for continuing care. A normal initial test may narrow some possibilities, but it does not measure the full effect of symptoms on eating, work or daily life. Ask what has been checked, what remains possible and what happens if symptoms continue.

UK qualifications, referrals and conflicts

Dietitian and dietician are protected titles in the UK, regulated by the Health and Care Professions Council. Check the HCPC register and ask about relevant experience, especially for complex restrictions or medical conditions. A registered dietitian can work with the treating team on nutrition within their professional scope.

The Association for Nutrition maintains a voluntary register of nutritionists. Nutritional therapy is not a statutorily regulated profession; a practitioner may belong to a voluntary register accredited by the Professional Standards Authority. Voluntary registration is not the same as statutory regulation or a medical qualification. Check the actual register, qualifications, scope and referral arrangements.

Ask who will communicate with your GP or specialist, with your permission, and what happens if a result needs urgent follow-up. Request full consultation and testing costs, repeat fees, product costs and any commission or affiliate relationship. A practitioner should be able to explain the evidence for each proposed intervention and acknowledge uncertainty.

Make the next appointment count

Bring a short timeline: when the problem began, the main change from your usual pattern, stool form and frequency, pain, meals, sleep, relevant menstrual changes, medicines and anything already tried. Include unintended weight change or difficulty eating and drinking. A concise record can help a clinician decide what requires attention without claiming that timing proves causation.

Choose two or three questions: “What are the main possibilities?” “Which investigations are appropriate and what would each result change?” “How will we maintain adequate food while trying this plan?” “Who will review my symptoms and when?” Request copies of results and a clear plan for contacting the team if circumstances change.

For sudden severe abdominal pain or if you cannot pass stool or wind, call 999 or go to A&E rather than waiting for a dietary trial. Other concerning symptoms may need urgent GP or NHS 111 advice. If symptoms persist or change, ask for reassessment. A useful plan makes room for relief now, appropriate investigation and a review of what happens next.